Build status - In Progress
Search filters

Filters
Clear All

Phase

  • 183
  • 152
  • 2
  • 191
  • 1
  • 148
  • 17
  • 390
  • 1223
  • 588
  • 29
  • 46
  • 3
  • 1151
  • 1223
  • 6

Found 1229 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

18 years - 99 years
All genders
Interventional
This is an extension study for subjects over the age of 18, diagnosed with moderate-to-severe atopic dermatitis and enrolled in our main study IRB # 845325. This research study is being conducted to test the safety of lebrikizumab and potential side effects. Procedures include Physical exams, Medical History, blood and …
 An Open-Label Study For Continued Treatment Access For Participants From The B9991032 Avelumab Study
18 years - 99 years
All genders
Phase 2
The purpose of the continuation sub-study is to provide continued treatment access for participants from the B9991032 Parent Study who are deriving benefit from study treatment as judged by the investigator.
18 years - 99 years
All genders
The purpose of this study is to assess the safety of ALM-488, and to learn how well it shows nerve tissue in the body.
99 years or below
All genders
Interventional
The purpose of this extension trial is to find out how safe and how well the trial drug, apraglutide, is tolerated when you are treated for up to 104 weeks and to see if there are any changes in how much parenteral support (PS) you need.
12 years - 99 years
All genders
Interventional
The purpose of this study is to provide study drug APT-1011 to patients with Eosinophilic Esophagitis who have no suitable approved standard therapies for treatment and who are not eligible for other clinical trials. In addition, this program will collect tolerability, safety, and efficacy information.
18 years - 75 years
All genders
Interventional
The purpose of this study is to provide information about the safety and long-term effectiveness of the BWI irreversible electroporation (IRE) ablation system consisting of the TRUPULSE™ Generator and VARIPULSE™ Catheter. The Biosense Webster Inc. (BWI) IRE Ablation system is being studied for use in the treatment of Paroxysmal Atrial …
18 years - 99 years
All genders
Phase 2
Interventional
The purpose of this study are to determine the maximum dose of FF-10832 that can be tolerated when taken in combination with pembrolizumab and to determine whether FF10832 taken by itself or in combination with pembrolizumab has anti-tumor activity.
18 years - 50 years
All genders
Interventional
COSMID is a pragmatic, patient-level randomized superiority trial of elective colectomy vs. best medical management for patients with quality of life (QoL) limiting diverticular disease. The goal of the COSMID trial is to answer the question: For patients with QoL-limiting diverticular disease, is elective colectomy more effective than best medical …
99 years or below
All genders
Interventional
The purpose of this study is to compare the effectiveness and implementation of two suicide prevention strategies for autistic youth: the Safety Planning Intervention tailored for Autistic individuals (SPI-A) and SPI-A plus follow-up care (SPI-A+). Participants are 150 clinicians and 1500 autistic youth (ages 15-24) who receive either SPI-A or …
99 years or below
Female
Interventional
This study is designed to evaluate the safety and effectiveness of the Materna Prep Device in reducing pelvic muscle injuries during vaginal delivery. Eligible participants will be women ages 18+ scheduled for vaginal birth.
1051 - 1060 of 1229